The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
Open accessAbstract
Objective: To evaluate the excess risk and relative hazards for developing incident clinical sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. Design: Retrospective cohort study. Setting: Three merged data sources from a large United States health plan: a large national administrative claims database, an outpatient laboratory testing database, and an inpatient hospital admissions database. Participants: Individuals aged 18-65 with continuous enrollment in the health plan from January 2019 to the date of a diagnosis of SARS-CoV-2 infection. Three comparator groups, matched by propensity score, to individuals infected with SARS-CoV-2: a 2020 comparator group, an historical 2019 comparator group, and an historical comparator group with viral lower respiratory tract illness. Main outcome measures: More than 50 clinical sequelae after the acute phase of SARS-CoV-2 infection (defined as the date of first SARS-CoV-2 diagnosis (index date) plus 21 days) were identified using ICD-10 (international classification of diseases, 10th revision) codes. Excess risk in the four months after acute infection and hazard ratios with Bonferroni corrected 95% confidence intervals were calculated. Results: 14% of adults aged ≤65 who were infected with SARS-CoV-2 (27 074 of 193 113) had at least one new type of clinical sequelae that required medical care after the acute phase of the illness, which was 4.95% higher than in the 2020 comparator group. The risk for specific new sequelae attributable to SARS-Cov-2 infection after the acute phase, including chronic respiratory failure, cardiac arrythmia, hypercoagulability, encephalopathy, peripheral neuropathy, amnesia (memory difficulty), diabetes, liver test abnormalities, myocarditis, anxiety, and fatigue, was significantly greater than in the three comparator groups (2020, 2019, and viral lower respiratory tract illness groups) (all P<0.001). Significant risk differences because of SARS-CoV-2 infection ranged from 0.02 to 2.26 per 100 people (all P<0.001), and hazard ratios ranged from 1.24 to 25.65 compared with the 2020 comparator group. Conclusions: The results indicate the excess risk of developing new clinical sequelae after the acute phase of SARS-CoV-2 infection, including specific types of sequelae less commonly seen in other viral illnesses. Although individuals who were older, had pre-existing conditions, and were admitted to hospital because of covid-19 were at greatest excess risk, younger adults (aged ≤50), those with no pre-existing conditions, or those not admitted to hospital for covid-19 also had an increased risk of developing new clinical sequelae. The greater risk for incident sequelae after the acute phase of SARS-CoV-2 infection is relevant for healthcare planning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
RetractedRegularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242 · cited 1×
“18 We constructed a propensity score for every individual based on 108 variables (age, number; sex, male yes/no; socioeconomic status scores specific to zip codes, number; proportion of white, black, and Hispanic populations in a zip code, number; state, 10 binary variables in the top 10 states of…”
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
Vindegaard, N., & Benros, M. E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.048 · Cited by 3,221
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
Attributes and predictors of long COVID
Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01292-y · Cited by 2,707
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407
Neurological associations of COVID-19
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156
Ridge Estimators in Logistic Regression
Cessie, S. L., & Houwelingen, J. C. V. (1992) · Applied Statistics · doi:10.2307/2347628 · Cited by 1,680
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
Self-citationTaquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., Smithline, H. A., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6930e1 · Cited by 1,319
Garrigues, E., Janvier, P., Kherabi, Y., Le Bot, A., Hamon, A., Gouze, H., Doucet, L., Berkani, S., Oliosi, E., Mallart, E., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.08.029 · Cited by 1,157
Psychological distress and loneliness reported by US adults in 2018 and April 2020
McGinty, E. E., Presskreischer, R., Han, H., & Barry, C. L. (2020) · JAMA · doi:10.1001/jama.2020.9740 · Cited by 978
Quan, H., Li, B., Duncan Saunders, L., Parsons, G. A., Nilsson, C. I., Alibhai, A., Ghali, W. A., & for the IMECCHI Investigators (2008) · Health Services Research · doi:10.1111/j.1475-6773.2007.00822.x · Cited by 892
Sequelae in Adults at 6 Months After COVID-19 Infection
Logue, J. K., Franko, N. M., McCulloch, D. J., McDonald, D., Magedson, A., Wolf, C. R., & Chu, H. Y. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.0830 · Cited by 880
Sixty-day outcomes among patients hospitalized with COVID-19
Chopra, V., Flanders, S. A., O’Malley, M., Malani, A. N., & Prescott, H. C. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5661 · Cited by 723
Malas, M. B., Naazie, I. N., Elsayed, N., Mathlouthi, A., Marmor, R., & Clary, B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100639 · Cited by 685
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
Moreno-Pérez, O., Merino, E., Leon-Ramirez, J.-M., Andres, M., Ramos, J. M., Arenas-Jiménez, J., Asensio, S., Sanchez, R., Ruiz-Torregrosa, P., Galan, I., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.01.004 · Cited by 674
van den Borst, B., Peters, J. B., Brink, M., Schoon, Y., Bleeker-Rovers, C. P., Schers, H., van Hees, H. W. H., van Helvoort, H., van den Boogaard, M., van der Hoeven, H., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1750 · Cited by 466
Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection
Wu, Q., Zhou, L., Sun, X., Yan, Z., Hu, C., Wu, J., Xu, L., Li, X., Liu, H., Yin, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09536-z · Cited by 439
The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection
Sellers, S. A., Hagan, R. S., Hayden, F. G., & Fischer, W. A. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12470 · Cited by 438
Encephalitis as a clinical manifestation of COVID-19
Ye, M., Ren, Y., & Lv, T. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.017 · Cited by 429
COVID-19 and cardiac arrhythmias
Bhatla, A., Mayer, M. M., Adusumalli, S., Hyman, M. C., Oh, E., Tierney, A., Moss, J., Chahal, A. A., Anesi, G., Denduluri, S., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.06.016 · Cited by 406
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re’em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2020) · medRxiv · doi:10.1101/2020.12.24.20248802 · Cited by 387
Follow-up chest radiographic findings in patients with MERS-CoV after recovery
Das, K. M., Lee, E. Y., Singh, R., Enani, M. A., Al Dossari, K., Van Gorkom, K., Larsson, S. G., & Langer, R. D. (2017) · Indian Journal of Radiology and Imaging · doi:10.4103/ijri.ijri_469_16 · Cited by 370
Cardiovascular complications of severe acute respiratory syndrome
Yu, C.-M., Wong, R. S.-M., Wu, E. B., Kong, S.-L., Wong, J., Yip, G. W.-K., Soo, Y. O. Y., Chiu, M. L. S., Chan, Y.-S., Hui, D., et al. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.037515 · Cited by 345
Schaefer, R. L., Roi, L. D., & Wolfe, R. A. (1984) · Communications in Statistics - Theory and Methods · doi:10.1080/03610928408828664 · Cited by 267
Proportion of newly diagnosed diabetes in COVID ‐19 patients: A systematic review and meta‐analysis
Sathish, T., Kapoor, N., Cao, Y., Tapp, R. J., & Zimmet, P. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14269 · Cited by 251
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review
Leung, T. Y. M., Chan, A. Y. L., Chan, E. W., Chan, V. K. Y., Chui, C. S. L., Cowling, B. J., Gao, L., Ge, M. Q., Hung, I. F. N., Ip, M. S. M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1825914 · Cited by 226
Clinical Outcomes in Young US Adults Hospitalized With COVID-19
Cunningham, J. W., Vaduganathan, M., Claggett, B. L., Jering, K. S., Bhatt, A. S., Rosenthal, N., & Solomon, S. D. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.5313 · Cited by 220
Chow, E. J., Rolfes, M. A., O'Halloran, A., Anderson, E. J., Bennett, N. M., Billing, L., Chai, S., Dufort, E., Herlihy, R., Kim, S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1509 · Cited by 162
Multi-organ impairment in low-risk individuals with long COVIDPreprint
Dennis, A., Wamil, M., Kapur, S., Alberts, J., Badley, A. D., Decker, G. A., Rizza, S. A., Banerjee, R., & Banerjee, A. (2020) · medRxiv · doi:10.1101/2020.10.14.20212555 · Cited by 122
Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study
Hill, J. B., Garcia, D. A., Crowther, M. A., Savage, B., Peress, S., Chang, K., & Deitelzweig, S. B. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003083 · Cited by 87
Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS)
Lau, S., Yu, W. C., Mok, N., Tsui, P., Tong, W., & Stella, W. C. C. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.06.022 · Cited by 53
Bonow, R. O., O’Gara, P. T., & Yancy, C. W. (2020) · JAMA · doi:10.1001/jama.2020.15088 · Cited by 53
Crabb, B. T., Lyons, A., Bale, M., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.17703 · Cited by 46
Josephson, S. A., & Kamel, H. (2020) · JAMA · doi:10.1001/jama.2020.14254 · Cited by 46
Winkelmayer, W. C., Khairallah, P., & Charytan, D. M. (2020) · JAMA · doi:10.1001/jama.2020.16779 · Cited by 15
Cited by
Long-term cardiovascular outcomes of COVID-19
Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-01689-3 · Cited by 2,029
Taquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003773 · Cited by 927
Long COVID after breakthrough SARS-CoV-2 infection
Al-Aly, Z., Bowe, B., & Xie, Y. (2022) · Nature Medicine · doi:10.1038/s41591-022-01840-0 · Cited by 866
Distinguishing features of long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., Tabacof, L., Malik, A. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06651-y · Cited by 806
Taquet, M., Sillett, R., Zhu, L., Mendel, J., Camplisson, I., Dercon, Q., & Harrison, P. J. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00260-7 · Cited by 740
Metadata
- Authors
- Daugherty, S. E., Guo, Y., Heath, K., Dasmariñas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., & Cohen, K.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-05-19
- Volume
- 373
- Pages
- n1098
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3163666887
- Cited by
- 435
- References
- 44
- FWCI
- 38.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.